Pet Genetic Testing Companies Are Making Promises They Can’t Keep
By Jessica Hekman,
Undark
| 09. 13. 2018
The promise of a sequenced genome is like a wrapped present, containing exactly what you always wanted but never knew you could get: predictions of all your future health problems and instructions for how to avoid them. Pet owners are the latest to fall prey to the myth of the “magic genome,” hoping that genetic testing will keep their animal companions alive and healthy for longer than ever before. The claims of many genetic testing companies encourage these unrealistic expectations.
The pet genetic testing industry has boomed in recent years as sequencing technology has improved and costs have plummeted. Several companies now tout direct-to-consumer tests that can screen companion animals, mostly dogs, for more than 150 genetic diseases including heart disease, kidney disease, and epilepsy. As a veterinarian and genomics researcher, I encounter dog owners who truly believe that genetic sequencing will save their animals’ lives.
What most pet genetic testing companies fail to make clear, though, is that genetic testing is riddled with uncertainty. Not all pets that test “clear” for a disease are truly safe from that condition...
Related Articles
By Jenny Lange, BioNews | 12.01.2025
A UK toddler with a rare genetic condition was the first person to receive a new gene therapy that appears to halt disease progression.
Oliver, now three years old, has Hunter syndrome, an inherited genetic disorder that leads to physical...
By Rachel Hall, The Guardian | 11.20.2025
Couples are needlessly going through IVF because male infertility is under-researched, with the NHS too often failing to diagnose treatable causes, leading experts have said.
Poor understanding among GPs and a lack of specialists and NHS testing means male infertility...
By Pam Belluck and Carl Zimmer, The New York Times | 11.19.2025
Gene-editing therapies offer great hope for treating rare diseases, but they face big hurdles: the tremendous time and resources involved in devising a treatment that might only apply to a small number of patients.
A study published on Wednesday...
By Aisha Down, The Guardian | 11.10.2025
It has been an excellent year for neurotech, if you ignore the people funding it. In August, a tiny brain implant successfully decoded the inner speech of paralysis patients. In October, an eye implant restored sight to patients who had...
